33

Guidance Document For Reporting Serious Adverse Reactions in

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Guidance Document For Reporting Serious Adverse Reactions in
HP
Typewritten Text
HP
Typewritten Text
HP
Typewritten Text
Page 2: Guidance Document For Reporting Serious Adverse Reactions in
Page 3: Guidance Document For Reporting Serious Adverse Reactions in
Page 4: Guidance Document For Reporting Serious Adverse Reactions in
Page 5: Guidance Document For Reporting Serious Adverse Reactions in
Page 6: Guidance Document For Reporting Serious Adverse Reactions in
Page 7: Guidance Document For Reporting Serious Adverse Reactions in
Page 8: Guidance Document For Reporting Serious Adverse Reactions in
Page 9: Guidance Document For Reporting Serious Adverse Reactions in
Page 10: Guidance Document For Reporting Serious Adverse Reactions in
Page 11: Guidance Document For Reporting Serious Adverse Reactions in
Page 12: Guidance Document For Reporting Serious Adverse Reactions in
Page 13: Guidance Document For Reporting Serious Adverse Reactions in
Page 14: Guidance Document For Reporting Serious Adverse Reactions in
Page 15: Guidance Document For Reporting Serious Adverse Reactions in
Page 16: Guidance Document For Reporting Serious Adverse Reactions in
Page 17: Guidance Document For Reporting Serious Adverse Reactions in
Page 18: Guidance Document For Reporting Serious Adverse Reactions in
Page 19: Guidance Document For Reporting Serious Adverse Reactions in
Page 20: Guidance Document For Reporting Serious Adverse Reactions in
Page 21: Guidance Document For Reporting Serious Adverse Reactions in
Page 22: Guidance Document For Reporting Serious Adverse Reactions in
Page 23: Guidance Document For Reporting Serious Adverse Reactions in
Page 24: Guidance Document For Reporting Serious Adverse Reactions in
Page 25: Guidance Document For Reporting Serious Adverse Reactions in
Page 26: Guidance Document For Reporting Serious Adverse Reactions in
Page 27: Guidance Document For Reporting Serious Adverse Reactions in
Page 28: Guidance Document For Reporting Serious Adverse Reactions in
Page 29: Guidance Document For Reporting Serious Adverse Reactions in
Page 30: Guidance Document For Reporting Serious Adverse Reactions in
HP
Typewritten Text
transfusion
HP
Typewritten Text
Page 31: Guidance Document For Reporting Serious Adverse Reactions in
Page 32: Guidance Document For Reporting Serious Adverse Reactions in
Page 33: Guidance Document For Reporting Serious Adverse Reactions in